(Q46054259)

19 December 2017

title

Expression of a dominant negative IFN-gammareceptor on mouse oligodendrocytes (English)

1 reference

19 December 2017

1 reference

John M González

1

0 references

Cornelia C. Bergmann

object named as

Cornelia C Bergmann

2

0 references

Wendy B Macklin

6

object named as

Wendy B Macklin

1 reference

19 December 2017

author name string

Babette Fuss

3

1 reference

19 December 2017

David R Hinton

4

1 reference

19 December 2017

Cindy Kangas

5

1 reference

19 December 2017

Stephen A Stohlman

7

1 reference

19 December 2017

publication date

1 July 2005

1 reference

19 December 2017

published in

Glia

1 reference

19 December 2017

volume

51

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

22-34

1 reference

19 December 2017

Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

Transgenic mouse model for central nervous system demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

Modification of Schwann cell phenotype with Plp transgenes: evidence that the PLP and DM20 isoproteins are targeted to different cellular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

The IFN gamma receptor: a paradigm for cytokine receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Microglia exhibit clonal variability in eliciting cytotoxic T lymphocyte responses independent of class I expression.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Cytokine gene expression in cells derived from CSF of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

The role of IFN-gamma in immune responses to viral infections of the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Correlation between interferon production and clinical disease activity in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Tissue-specific targeting of cytokine unresponsiveness in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Treatment with anti-interferon-gamma monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-gamma receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Identification of a functionally important sequence in the C terminus of the interferon-gamma receptor.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

https://api.crossref.org/works/10.1002%2FGLIA.20182

1 reference

7 January 2021

Immunopathogenesis of demyelination induced by MHV-4.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

IFN-gamma production by antigen-presenting cells: mechanisms emerge.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Normal CNS myelination in transgenic mice overexpressing MHC class I H-2L(d) in oligodendrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

CNS antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Primary demyelination in transgenic mice expressing interferon-gamma

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Immune response in mice that lack the interferon-gamma receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Failure of central nervous system myelination in MBP/c-myc transgenic mice: evidence for c-myc cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Interaction between the components of the interferon gamma receptor complex

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Signaling by covalent heterodimers of interferon-gamma. Evidence for one-sided signaling in the active tetrameric receptor complex

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Mechanisms of viral clearance in perforin-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Cytokine mRNA expression in CSF and peripheral blood mononuclear cells in multiple sclerosis: detection by RT-PCR without in vitro stimulation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Major histocompatibility complex Class I expression in oligodendrocytes induces hypomyelination in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

The major myelin protein genes are expressed in the human thymus.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Is apoptotic death of the oligodendrocyte a critical event in the pathogenesis of multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Interferon-γ: an overview of signals, mechanisms and functions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Developing oligodendroglia express mRNA for insulin-like growth factor-I, a regulator of oligodendrocyte development

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Location of antibody epitopes within the mouse hepatitis virus nucleocapsid protein

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

MHC antigen expression on glial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

The expression of MHC antigens on oligodendrocytes: induction of polymorphic H-2 expression by lymphokines

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-gamma and TNF-alpha.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

A myelin proteolipid protein-LacZ fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Inducible expression of H-2 and Ia antigens on brain cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Interferon-gamma induces the expression of H-2 and Ia antigens on brain cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Identification of a CD4+ T cell epitope within the M protein of a neurotropic coronavirus

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20182

7 January 2021

Identifiers

DOI

10.1002/GLIA.20182

1 reference

19 December 2017

1 reference

19 December 2017